Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yvonne Resch is active.

Publication


Featured researches published by Yvonne Resch.


Journal of Immunology | 2013

Identification of Der p 23, a Peritrophin-like Protein, as a New Major Dermatophagoides pteronyssinus Allergen Associated with the Peritrophic Matrix of Mite Fecal Pellets

Margit Weghofer; Monika Grote; Yvonne Resch; Anne Casset; Michael Kneidinger; Jolanta Kopec; Wayne R. Thomas; Enrique Fernández-Caldas; Michael Kabesch; Rosetta Ferrara; Adriano Mari; Ashok Purohit; G. Pauli; Friedrich Horak; Walter Keller; Peter Valent; Rudolf Valenta; Susanne Vrtala

The house dust mite (HDM) Dermatophagoides pteronyssinus is one of most important allergen sources and a major elicitor of allergic asthma. We screened a D. pteronyssinus expression cDNA library with IgE Abs from HDM allergic patients. A cDNA coding for a new major allergen was isolated, which showed sequence homology to peritrophins, which contain chitin-binding domains and are part of the peritrophic matrix lining the gut of arthropods. The mature Der p 23 allergen was expressed in Escherichia coli as an 8-kDa protein without its hydrophobic leader sequence and purified to homogeneity. It reacted with IgE Abs from 74% of D. pteronyssinus allergic patients (n = 347) at levels comparable to the two major HDM allergens, Der p 1 and Der p 2. Thus, Der p 23 represents a new major D. pteronyssinus allergen. Furthermore, rDer p 23 exhibited high allergenic activity as demonstrated by upregulation of CD203c expression on basophils from D. pteronyssinus allergic patients. Immunogold electron microscopy localized the allergen in the peritrophic matrix lining the midgut of D. pteronyssinus as well as on the surface of the fecal pellets. Thus, we identified a new major D. pteronyssinus allergen as peritrophin-like protein. The high allergenic activity of Der p 23 and its frequent recognition as respiratory allergen may be explained by the fact that it becomes airborne and respirable through its association with mite feces. Der p 23 may be an essential component for diagnosis and specific immunotherapy of HDM allergy.


International Archives of Allergy and Immunology | 2012

Varying Allergen Composition and Content Affects the in vivo Allergenic Activity of Commercial Dermatophagoides pteronyssinus Extracts

Anne Casset; Adriano Mari; Ashok Purohit; Yvonne Resch; Margit Weghofer; Rosetta Ferrara; Wayne R. Thomas; Claudia Alessandri; Kuan-Wei Chen; Frederic de Blay; Rudolf Valenta; Susanne Vrtala

Background: Diagnosis and immunotherapy of house-dust mite (HDM) allergy is still based on natural allergen extracts. The aim of this study was to analyze commercially available Dermatophagoides pteronyssinus extracts from different manufacturers regarding allergen composition and content and whether variations may affect their allergenic activity. Methods: Antibodies specific for several D. pteronyssinus allergens (Der p 1, 2, 5, 7, 10 and 21) were used to analyze extracts from 10 different manufacturers by immunoblotting. Sandwich ELISAs were used to quantify Der p 1 and Der p 2 in the extracts. Mite-allergic patients (n = 45) were skin-tested with the extracts and tested for immunoglobulin E (IgE) reactivity to a panel of 10 mite allergens (Der p 1, 2, 4, 5, 7, 8, 10, 14, 20 and 21) by dot blot. Results: Only Der p 1 and Der p 2 were detected in all extracts but their concentrations and ratios showed high variability (Der p 1: 6.0–40.8 µg ml–1; Der p 2: 1.7–45.0 µg ml–1). At least 1 out of 4 allergens (i.e. Der p 5, 7, 10 and 21) was not detected in 8 of the studied extracts. Mite-allergic subjects showed different IgE reactivity profiles to the individual mite allergens, the extracts showed different allergenic activity in skin-prick tests and false-negative results. Conclusions: Commercially available D. pteronyssinus extracts lack important allergens, show great variability regarding allergen composition and content and some gave false-negative diagnostic test results in certain patients.


Clinical & Experimental Allergy | 2011

Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy

Yvonne Resch; Margit Weghofer; Seiberler S; F. Horak; Sandra Scheiblhofer; Birgit Linhart; Ines Swoboda; Wayne R. Thomas; Josef Thalhamer; R. Valenta; Susanne Vrtala

Background Tropomyosins represent clinically relevant seafood allergens but the role of mite tropomyosin, Der p 10, in house dust mite (HDM) allergy has not been studied in detail.


Journal of Investigative Dermatology | 2015

Der p 11 Is a Major Allergen for House Dust Mite-Allergic Patients Suffering from Atopic Dermatitis

Srinita Banerjee; Yvonne Resch; Kuan-Wei Chen; Ines Swoboda; Margit Focke-Tejkl; Katharina Blatt; Natalija Novak; Magnus Wickman; Marianne van Hage; Rosetta Ferrara; Adriano Mari; Ashok Purohit; Gabrielle Pauli; Elopy Sibanda; Portia Ndlovu; Wayne R. Thomas; Vladislav Krzyzanek; Sebastian Tacke; Ursula Malkus; Peter Valent; Rudolf Valenta; Susanne Vrtala

House dust mites (HDMs) belong to the most potent indoor allergen sources worldwide and are associated with allergic manifestations in the respiratory tract and the skin. Here we studied the importance of the high-molecular-weight group 11 allergen from Dermatophagoides pteronyssinus (Der p 11) in HDM allergy. Sequence analysis showed that Der p 11 has high homology to paramyosins from mites, ticks, and other invertebrates. A synthetic gene coding for Der p 11 was expressed in Escherichia coli and rDer p 11 purified to homogeneity as folded, alpha-helical protein as determined by circular dichroism spectroscopy. Using antibodies raised against rDer p 11 and immunogold electron microscopy, the allergen was localized in the muscle beneath the skin of mite bodies but not in feces. IgE reactivity of rDer p 11 was tested with sera from HDM-allergic patients from Europe and Africa in radioallergosorbent test-based dot-blot assays. Interestingly, we found that Der p 11 is a major allergen for patients suffering from atopic dermatitis (AD), whereas it is only a minor allergen for patients suffering from respiratory forms of HDM allergy. Thus, rDer p 11 might be a useful serological marker allergen for the identification of a subgroup of HDM-allergic patients suffering from HDM-associated AD.


The Journal of Allergy and Clinical Immunology | 2017

Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life

Daniela Posa; Serena Perna; Yvonne Resch; Christian Lupinek; Valentina Panetta; Stephanie Hofmaier; Alexander Rohrbach; Laura Hatzler; Linus Grabenhenrich; Olympia Tsilochristou; Kuan-Wei Chen; Carl-Peter Bauer; Ute Hoffman; Johannes Forster; Fred Zepp; Antje Schuster; Ulrich Wahn; Thomas Keil; Susanne Lau; Susanne Vrtala; Rudolf Valenta; Paolo Maria Matricardi

Background: The evolution of the IgE response to the numerous allergen molecules of Dermatophagoides pteronyssinus is still unknown. Objectives: We sought to characterize the evolutionary patterns of the IgE response to 12 molecules of D pteronyssinus from birth to adulthood and to investigate their determinants and clinical relevance. Methods: We investigated the clinical data and sera of 722 participants in the German Multicenter Allergy Study, a birth cohort started in 1990. Diagnoses of current allergic rhinitis (AR) related to mite allergy and asthma were based on yearly interviews at the ages of 1 to 13 years and 20 years. IgE to the extract and 12 molecules of D pteronyssinus were tested by means of ImmunoCAP and microarray technology, respectively, in sera collected at ages 1, 2, 3, 5, 6, 7, 10, 13, and 20 years. Exposure to mites at age 6 and 18 months was assessed by measuring Der p 1 weight/weight concentration in house dust. Results: One hundred ninety‐one (26.5%) of 722 participants ever had IgE to D pteronyssinus extract (≥0.35 kUA/L). At age 20 years, their IgE recognized most frequently Der p 2, Der p 1, and Der p 23 (group A molecules; prevalence, >40%), followed by Der p 5, Der p 7, Der p 4, and Der p 21 (group B molecules; prevalence, 15% to 30%) and Der p 11, Der p 18, clone 16, Der p 14, and Der p 15 (group C molecules; prevalence, <10%). IgE sensitization started almost invariably with group A molecules and expanded sequentially first to group B and finally to group C molecules. Early IgE sensitization onset, parental hay fever, and higher exposure to mites were associated with a broader polymolecular IgE sensitization pattern. Participants reaching the broadest IgE sensitization stage (ie, ABC) had significantly higher risk of mite‐related AR and asthma than unsensitized participants. IgE to Der p 1 or Der p 23 at age 5 years or less predicted asthma at school age. Conclusions: Parental hay fever and early exposure to D pteronyssinus allergens promote IgE polysensitization to several D pteronyssinus molecules, which in turn predicts current mite‐related AR and current/future asthma. These results might inspire predictive algorithms and prevention strategies against the progression of IgE sensitization to mites toward AR and asthma.


The Journal of Allergy and Clinical Immunology | 2015

Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children.

Yvonne Resch; Sven Michel; Michael Kabesch; Christian Lupinek; Rudolf Valenta; Susanne Vrtala

Background House dust mites (HDMs) represent one of the most important inducers of respiratory allergies worldwide. Objective We sought to investigate the IgE and IgG reactivity profiles to a comprehensive panel of HDM allergens in children with allergic asthma and to compare them with those of nonasthmatic atopic children. Methods Sera from clinically well-characterized asthmatic children with HDM allergy (n = 105), nonasthmatic children (n = 53), and nonatopic nonasthmatic children (n = 53) were analyzed for IgE and IgG reactivity to a panel of 7 HDM allergens (nDer p 1, rDer p 2, rDer p 5, rDer p 7, rDer p 10, rDer p 21, and rDer p 23) by means of allergen microarray technology. Results Asthmatic children with HDM allergy more frequently showed an IgE response to each of the HDM allergens and recognized more allergens than nonasthmatic children with HDM allergy. Furthermore, IgE levels to certain HDM allergens (nDer p 1, P = .002; rDer p 2, P = .007; rDer p 5, P = .031; and rDer p 23, P < .001) were significantly higher in asthmatic children than in children without asthma. By contrast, fewer asthmatic children showed IgG reactivity to HDM allergens than nonasthmatic children, but allergen-specific IgG levels were comparable. Conclusion The IgE and IgG reactivity profiles to HDM allergens, as well as IgE levels to certain allergen components, differed considerably between children with and without asthmatic symptoms caused by HDM allergy. In fact, asthmatic children were characterized by an expanded IgE repertoire regarding the numbers of recognized allergen components and by increased specific IgE levels.


The Journal of Allergy and Clinical Immunology | 2017

Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study

V. Siroux; Christian Lupinek; Yvonne Resch; Mirela Curin; Jocelyne Just; Thomas Keil; Renata Kiss; Karin C. Lødrup Carlsen; Erik Melén; Rachel Nadif; Isabelle Pin; I. Skrindo; Susanne Vrtala; M. Wickman; Josep M. Antó; Rudolf Valenta; Jean Bousquet

Background: The nature of allergens and route and dose of exposure may affect the natural development of IgE and IgG responses. Objective: We sought to investigate the natural IgE and IgG responses toward a large panel of respiratory and food allergens in subjects exposed to different respiratory allergen loads. Methods: A cross‐sectional analysis was conducted in 340 adults of the EGEA (Epidemiological study of the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy) (170 with and 170 without asthma) cohort. IgE and IgG responses to 47 inhalant and food allergen components were analyzed in sera using allergen microarray and compared between 5 French regions according to the route of allergen exposure (inhaled vs food allergens). Results: Overall 48.8% of the population had allergen‐specific IgE levels of 0.3 ISAC standardized units (ISU) or more to at least 1 of the 47 allergens with no significant differences across the regions. For ubiquitous respiratory allergens (ie, grass, olive/ash pollen, house dust mites), specific IgE did not show marked differences between regions and specific IgG (≥0.5 ISU) was present in most subjects everywhere. For regionally occurring pollen allergens (ragweed, birch, cypress), IgE sensitization was significantly associated with regional pollen exposure. For airborne allergens cross‐reacting with food allergens, frequent IgG recognition was observed even in regions with low allergen prevalence (Bet v 1) or for allergens less frequently recognized by IgE (profilins). Conclusions: The variability in allergen‐specific IgE and IgG frequencies depends on exposure, route of exposure, and overall immunogenicity of the allergen. Allergen contact by the oral route might preferentially induce IgG responses.


International Archives of Allergy and Immunology | 2016

Real-Life Study for the Diagnosis of House Dust Mite Allergy - The Value of Recombinant Allergen-Based IgE Serology

Sven Becker; Thomas Schlederer; Matthias F. Kramer; Mareike Haack; Susanne Vrtala; Yvonne Resch; Christian Lupinek; Rudolf Valenta; Moritz Gröger

Background:Dermatophagoides pteronyssinus is one of the most important perennial allergen sources worldwide. Molecular diagnostics using the commercially available major allergens (Der p 1 and Der p 2) in combination with Der p 10 do not detect house dust mite (HDM) sensitization in a number of cases when used alone. The objective was to evaluate the IgE reactivity profiles of these patients using an experimental immunoassay biochip. Methods: Sera of HDM-allergic patients (positive skin prick test, CAP class ≥1 for allergen extract, and positive intranasal provocation) were tested for IgE antibodies against Der p 1, Der p 2, and Der p 10 by ImmunoCAP fluorescence enzyme immunoassay. Negatively tested sera were examined by an experimental chip containing 13 microarrayed HDM allergens. Results: Of 97 patients tested, 16 showed negative results to Der p 1, Der p 2, and Der p 10. MeDALL chip evaluation revealed 5 patients monosensitized to Der p 23, and 11 patients were negative for all HDM MeDALL chip components. Seven sera were available for further testing, and 3 of them showed IgE reactivity to dot-blotted nDer p 1, and 2 reacted with high-molecular weight components (>100 kDa) in nitrocellulose-blotted HDM extract when tested with 125I-labeled anti-IgE in a RAST-based assay. The HDM extract-specific IgE levels of the 11 patients were <3.9 kU/l. Conclusions: Recombinant allergen-based IgE serology is of great value when conventional IgE diagnostics fails. Der p 23 is an important HDM allergen, especially when major allergens are negative. Therefore, it would be desirable to have Der p 23 commercially available. Further research concerning the prevalence and clinical significance of different HDM allergens is needed.


PLOS ONE | 2016

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen.

Yvonne Resch; Katharina Blatt; Ursula Malkus; Fercher C; Ines Swoboda; Margit Focke-Tejkl; Kuan-Wei Chen; Seiberler S; Irene Mittermann; Christian Lupinek; Rodriguez-Dominguez A; Petra Zieglmayer; Zieglmayer R; Walter Keller; Krzyzanek; Peter Valent; R. Valenta; Susanne Vrtala

Background The house dust mite (HDM) allergen Der p 18 belongs to the glycoside hydrolase family 18 chitinases. The relevance of Der p 18 for house dust mite allergic patients has only been partly investigated. Objective To perform a detailed characterization of Der p 18 on a molecular, structural and immunological level. Methods Der p 18 was expressed in E. coli, purified to homogeneity, tested for chitin-binding activity and its secondary structure was analyzed by circular dichroism. Der p 18-specific IgG antibodies were produced in rabbits to localize the allergen in mites using immunogold electron microscopy and to search for cross-reactive allergens in other allergen sources (i.e. mites, crustacea, mollusca and insects). IgE reactivity of rDer p 18 was tested with sera from clinically well characterized HDM-allergic patients (n = 98) and its allergenic activity was analyzed in basophil activation experiments. Results Recombinant Der p 18 was expressed and purified as a folded, biologically active protein. It shows weak chitin-binding activity and partial cross-reactivity with Der f 18 from D. farinae but not with proteins from the other tested allergen sources. The allergen was mainly localized in the peritrophic matrix of the HDM gut and to a lower extent in fecal pellets. Der p 18 reacted with IgE from 10% of mite allergic patients from Austria and showed allergenic activity when tested for basophil activation in Der p 18-sensitized patients. Conclusion Der p 18 is a rather genus-specific minor allergen with weak chitin-binding activity but exhibits allergenic activity and therefore should be included in diagnostic test panels for HDM allergy.


The Journal of Allergy and Clinical Immunology | 2017

Reliable mite-specific IgE testing in nasal secretions by means of allergen microarray

Margot Berings; Stefania Arasi; Natalie De Ruyck; Serena Perna; Yvonne Resch; Christian Lupinek; Kuan-Wei Chen; Susanne Vrtala; Giovanni B. Pajno; Claus Bachert; Bart N. Lambrecht; Melissa Dullaers; Rudolf Valenta; Paolo Maria Matricardi; Philippe Gevaert

To the Editor: Because there is evidence for local production of IgE in the nasal mucosa, methods to measure allergen-specific IgE (sIgE) at nasal level in patients with allergic rhinitis (AR) are of great interest. Nasal secretions (NasSec) are easily collected with various noninvasive methods and are suitable for IgE measurements. Nevertheless, IgE ‘‘classic’’ assays, based on immunoenzymatic methods and allergen extracts, require large volumes and are inefficient in detecting the low amounts of IgE in NasSec. Microarray biochips allow simultaneous measurement of IgE against several allergen molecules with excellent sensitivity and specificity. To our knowledge, this technology has never been tested in NasSec of patients with AR. To fill this gap, we tested the performance of a customized microarray containing 15 house dust mite (HDM) allergen molecules based on the Immunoassay capture test (ImmunoCAP) ImmunoCAP solid-phase allergen chip technology (Thermo Fisher Scientific, Uppsala, Sweden) for sIgE detection in NasSec of 30 adult patients with HDM-AR and 29 nonallergic controls (see Table E1 in this article’s Online Repository at www.jacionline.org). All subjects were recruited via the Department of Otorhinolaryngology in Ghent University Hospital (Belgium). HDM-AR was defined by a consistent history and a positive skin prick test (SPT) result to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae (ALK Abell o, The Netherlands). Controls were volunteers without history of any allergy, and negative SPT results. Eligible subjects underwent collection of serum and NasSec.

Collaboration


Dive into the Yvonne Resch's collaboration.

Top Co-Authors

Avatar

Susanne Vrtala

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Rudolf Valenta

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Christian Lupinek

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Kuan-Wei Chen

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Wayne R. Thomas

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Margit Weghofer

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Peter Valent

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Michael Kabesch

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Ashok Purohit

University of Strasbourg

View shared research outputs
Top Co-Authors

Avatar

Adriano Mari

National Health Service

View shared research outputs
Researchain Logo
Decentralizing Knowledge